Cambridge Innovation Capital — Full Portfolio

Deeptech Labs is a seed-stage venture capital firm and accelerator focused on deep technology companies founded with the University of Cambridge and industry partners including Arm and Cambridge Innovation Capital.

AI & Machine LearningDeep TechCambridge, GB

MKMiles Kirby(Chief Executive Officer)in

BoardEwan Kirk(Investor and Chair)

Co-investorsARARMEMEMV Capital

Imagen builds a video management platform designed to help clients make video content measurable, manageable, and profitable.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareMedia & EntertainmentSaaSLondon, GB

Anthony BlakePaul McConkey

Co-investorsGUGuinness VenturesCACadenzaHAHaystackMEMenlo VenturesSCScript Capital

Immutrin is a biotechnology company developing antibody therapies designed to remove systemic amyloid deposits and reverse amyloidosis.

BiotechMedical Devices

MPMark Pepys(Co-founder; Emeritus Professor of Medicine at UCL)GWGregory Winter(Co-founder; Nobel Laureate)DCDaniel Christ(Co-founder; Professor, Faculty of Medicine, UNSW)

Co-investorsFRFrazier Life SciencesQIQiming Venture PartnersF-F-Prime CapitalSRSR One Capital Management

Pragmatic is a European semiconductor company developing clean chips designed to reduce carbon emissions and waste compared to silicon alternatives.

CleantechDeep TechHardwareSemiconductorsCambridge, GB

SWScott WhiteinRPRichard Pricein

Co-investorsINIn-Q-TelPRProsperity7 VenturesARARMBRBritish Patient CapitalCACatalystNONorth East Development Capital Fund+4 more

Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.

BiotechDeep TechHealthtechMedical Devices

MMMichal Minczuk(Co-Founder)inGMGabriel Martinez(Chief Scientific Officer & Co-Founder)CGClaes Gustafsson(Co-Founder)MFMaria Falkenberg(Co-Founder)NLNils-Göran Larsson(Co-Founder)Gabriel Martinez, Ph.D.(Chief Scientific Officer & Co-Founder)

Co-investorsARARCH Venture PartnersEIEIR VenturesANAngelini VenturesGVGV (Google Ventures)HEHealthCap

Secondmind provides AI-powered software to help automotive engineers accelerate vehicle design and development.

AI & Machine LearningDeep TechSaaSCambridge, GB

CECarl Edward Rasmussen(Chief Science Officer)inGBGary Brotman(Chief Executive Officer & Founder)in

Co-investorsAMAmadeus Capital PartnersATAtlantic Bridge VenturesREReefknot Investments

TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.

BiotechDeep TechLongevityMedical DevicesCambridge, GB

Damian Crowther, PhD FRCP(Co-founder, Head of Research)Dr. Leo James(Co-founder, Group Leader at MRC Laboratory of Molecular Biology)Dr. William McEwan(Co-founder, Group Leader at UK Dementia Research Institute, University of Cambridge)Nicki Thompson, PhD(CEO)Nicki Thompson(CEO)

Co-investorsPFPfizer VenturesSVSV Health InvestorsPFPfizer Venture Investments

52North Health develops NeutroCheck, a diagnostic tool that identifies neutropenia in chemotherapy patients presenting with fever, enabling risk stratification and reducing unnecessary emergency department visits.

BiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Co-investorsMEMeridian Health VenturesCACambridge Angels groupFUFuture Planet CapitalPAParkwalk AdvisorsMIMilltrust International Group

BeyondMath develops a foundational AI model trained on physics principles that enables generative design across industries.

AI & Machine LearningDeep TechEnterprise Software

AlanDarren

Co-investorsUPUP Partners

Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics.

CleantechDeep TechEnergyHardwareSemiconductorsCambridge, GB

FNFabio Necco(CEO)in

Co-investorsEMEMV CapitalIQIQ CapitalMAMartlet CapitalBRBritish Patient CapitalPAParkwalk Advisors

Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBoston, US

TPTimothy Pearson(CEO)ABAsh Bahl(CSO)inJHJenny Horsfield(CBO)inSMStuart McIntosh(CMO)inDSDavid Sutherland(VP Finance & Controller)

Co-investorsARARCH Venture PartnersB B Capital GroupB4B4 CapitalLILightstone Ventures

Centessa is a biopharmaceutical company developing an Orexin Receptor 2 Agonist program aimed at treating sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders.

BiotechHealthtech

Co-investorsADAdvent Life SciencesECEcoR1 CapitalFOForesite CapitalMEMedicxiOBOberland CapitalSCScion Life Sciences+1 more

CMR Surgical develops Versius, a small, modular, and portable surgical robot that enables hospitals and surgeons to perform minimal access (keyhole) surgery.

HealthtechMedical DevicesRobotics

MCMassimillano Colella(Chief Executive Officer)

Co-investorsLILightrockSASandwaterSOSoftBank Vision FundWAWatrium

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

RHRafiq Hasan(CEO and Managing Director)inMAMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsHAHadean VenturesSESeroba Life SciencesBGBGVBIBioGeneration VenturesFOForbionGIGimv+2 more

Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB

Co-investorsQVQVenturesAMAmadeus Capital PartnersFUFuture Planet CapitalIDIDO InvestmentsLELegal & GeneralPAParkwalk Advisors+1 more

Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured.

BiotechDeep TechNew Materials

JCJason Chin(Professor)

Co-investors+N+ND CapitalAMAmadeus Capital PartnersFIFine Structures VenturesGEGENERAL INCEPTIONLOLongeVCOMOMX Ventures+3 more

Cytora provides AI-powered risk processing software for commercial insurance carriers and brokers to automate underwriting, claims decisions, and portfolio management.

AI & Machine LearningEnterprise SoftwareInsurTech

RHRichard Hartley(Co-Founder)inAWAeneas Wiener(Co-Founder, CTO)in

Co-investorsEQEQT VenturesCLClaret Capital PartnersPAParkwalk Advisors

Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform.

AI & Machine LearningBiotechHealthtechMontreal, CA

CPClaude PerreaultPTPierre Thibault

Co-investorsADAdvent Life SciencesCTCTI Life Sciences Fund L.P.ADadMare BioInnovationsFOFonds de solidarité FTQ

Exciting Instruments builds the EI-FLEX benchtop platform, a single-molecule fluorescence instrument combining smFRET, FCS and FCCS to measure biomolecular interactions and dynamics directly in solution.

BiotechDeep TechHardware

Timothy Craggs(Founder and CEO)

Co-investorsNONorthern GritstoneEMEmpirical VenturesPRPraetura Ventures

Fluidic Sciences develops in-solution technologies and instruments for protein interaction analysis, enabling researchers to measure how proteins interact without immobilization complexities.

AI & Machine LearningBiotechDeep TechHardware

JWJames Wilkinson(Chief Executive Officer)in

BoardMark Gilligan(Chairman)

Co-investorsHEHeran PartnersDRDraper Esprit

GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOxford, GB

Co-investorsMAMaven Capital Partners

Novartis is a pharmaceutical company that develops and commercializes prescription medicines and therapies across therapeutic areas including oncology, cardiovascular disease, and immunology.

BiotechMedical Devices

Co-investorsSOSofinnova Ventures

Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease.

BiotechDigital HealthHealthtechMedical DevicesCambridge, GB

TLTrevor Lawley(Co-founder and CSO)in

Co-investorsSESeventure PartnersDCDCVC (Data Collective)

A biopharmaceutical company operating in early drug development, commercialization, and life cycle management within the therapeutics and life sciences industry.

Biotech

Nuclera provides multiplex protein screening technology for life science researchers, enabling faster access to and testing of proteins for drug discovery and development.

AI & Machine LearningBiotechDeep TechHardwareCambridge, US

Co-investorsBRBritish Business BankAMAmadeus Capital PartnersFUFuture Planet Capital

Origami is an AI-powered platform that helps sales teams identify and enrich prospective customers through intelligent prospecting and signal-based lead generation.

AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Francisco, US

FMFinn Mallery(Founder)inKCKenson Chung(Founder)in

Co-investorsY Y CombinatorOCOctopus Ventures

AI prospecting platform whose research agents build verified B2B lead lists from a natural-language prompt using live web search.

FMFinn Mallery(Founder)in

Co-investorsAPAppWorks VenturesVAValor Capital GroupOCOctopus VenturesPRPruVen Capital Partners

Novel antibody-based therapeutics platform for animal health.

Co-investorsCOCompanion FundDIDigitalis VenturesPAParkwalk Advisors

Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies.

AI & Machine LearningHealthtechMedical Devices

Co-investorsADAdara VenturesAMAmadeus Capital PartnersAPAPEX VenturesLILifeX VenturesASAsabys PartnersCOColumbus Venture Partners+1 more

Riverlane builds quantum error correction hardware and software, including its Deltaflow real-time QEC system, for quantum computer makers.

SBSteve Brierley(Founder)in

Co-investorsAMAmadeus Capital PartnersETETF PartnersMOMolten Ventures

Spin-out from the Universities of Oxford and Munster developing a novel semiconductor chip.

VKVaysh Kewada(Founder)in

Co-investorsOXOxford Science EnterprisesPEPerivoli InnovationsSISilicon CatalystAPApplied VenturesDEDeeptech Labs

Seldon provides a Kubernetes-native MLOps and LLMOps platform for deploying, scaling, and governing machine learning and AI models in production across any cloud or on-premise environment.

AI & Machine LearningCloud ComputingDeveloper ToolsLondon, GB

Co-investorsALAlbionVCBRBright Pixel CapitalTETechstarsAMAmadeus Capital PartnersPLPlayfair Capital

Forefront RF develops tunable RF duplexer technology for mobile and cellular devices, replacing multiple fixed RF components with a single adaptive, software-defined solution.

Deep TechHardwareSemiconductors

Co-investorsCACambridge Angels groupOCOctopus Ventures

Shift Bioscience develops siRNA therapeutics for cell rejuvenation, using a target identification platform that has identified an anti-fibrotic candidate initially aimed at liver fibrosis.

AI & Machine LearningBiotechLongevityCambridge, GB

DIDaniel Ives(Founder & CEO)inBSBrendan Swain(Co-founder & CSO)in

Co-investorsF-F-Prime CapitalKIKindred Capital

Sortera Bio develops biotechnology solutions, with a team of scientists and engineers specializing in microfluidics, software, and platform operations.

AI & Machine LearningBiotechDeep Tech

Ben Porebski(CEO-CTO, Founder)Philipp Holliger(Founder)

STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.

BiotechHealthtechMedical Devices

Co-investorsFAFast Track InitiativeM M VenturesPFPfizer Venture InvestmentsSESeroba Life SciencesTATaiho Ventures, LLCUTUTokyo Innovation Platform Co. Ltd.+1 more

T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB

Co-investorsF-F-Prime CapitalSASanofi VenturesSOSofinnova PartnersDIDigitalis Ventures

UnlikelyAI builds AI technology designed to support real-world decision-making through interpretable and trustworthy models.

AI & Machine LearningEnterprise Software

Co-investorsAMAmadeus Capital PartnersCACambridge Angels groupMEMetaplanetMSMS&AD VenturesOCOctopus Ventures